Key Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Sell
48,466
-3,950
-8% -$105K 0.23% 79
2026
Q2
$1.26M Sell
52,416
-7,942
-13% -$208K 0.21% 93
2026
Q1
$1.69M Sell
60,358
-670
-1% -$17.8K 0.3% 63
2025
Q4
$1.52M Sell
61,028
-2,452
-4% -$61.8K 0.28% 65
2025
Q3
$1.73M Sell
63,480
-941
-1% -$23.2K 0.32% 62
2025
Q2
$1.56M Sell
64,421
-3,115
-5% -$72.6K 0.31% 60
2025
Q1
$1.71M Sell
67,536
-1,485
-2% -$38.9K 0.37% 54
2024
Q4
$1.83M Sell
69,021
-2,997
-4% -$81.3K 0.42% 49
2024
Q3
$2.08M Sell
72,018
-477
-0.7% -$13.9K 0.46% 46
2024
Q2
$2.03M Sell
72,495
-711
-1% -$19.6K 0.49% 44
2024
Q1
$2.03M Buy
73,206
+114
+0.2% +$3.16K 0.52% 40
2023
Q4
$2.1M Sell
73,092
-3,512
-5% -$106K 0.58% 35
2023
Q3
$2.54M Sell
76,604
-1,426
-2% -$50.4K 0.86% 26
2023
Q2
$2.86M Sell
78,030
-469
-0.6% -$18.3K 0.95% 21
2023
Q1
$3.2M Buy
78,499
+2,369
+3% +$102K 1.17% 18
2022
Q4
$3.33M Hold
76,130
– – 1.57% 14
2022
Q3
$3.33M Buy
76,130
+34,759
+84% +$1.69M 1.57% 14
2022
Q2
$2.16M Buy
41,371
+741
+2% +$37.8K 1.17% 14
2022
Q1
$2.1M Buy
40,630
+5,589
+16% +$290K 1.05% 18
2021
Q4
$2.07M Buy
35,041
+80
+0.2% +$3.96K 1.04% 21
2021
Q3
$1.5M Buy
34,961
+1,800
+5% +$79.7K 0.85% 25
2021
Q2
$1.42M Sell
33,161
-4,331
-12% -$168K 0.79% 25
2021
Q1
$1.36M Buy
37,492
+4,915
+15% +$175K 0.9% 22
2020
Q4
$1.2M Sell
32,577
-6,631
-17% -$243K 0.89% 24
2020
Q3
$1.36M Buy
39,208
+4,707
+14% +$165K 1.4% 19
2020
Q2
$1.07M Sell
34,501
-5,930
-15% -$201K 1.22% 22
2020
Q1
$1.25M Sell
40,431
-1,746
-4% -$59.5K 1.29% 16
2019
Q4
$1.57M Buy
+42,177
New +$1.5M 1.47% 14

Other funds holding PFE

Key Financial's PFE Position: Q3 2026 in Review

Key Financial reduced its Pfizer (PFE) stake by 7.5% in Q3 2026, selling an estimated $105K and leaving 48,466 shares worth $1.38M. The position accounts for 0.23% of the portfolio, ranked #79.

Key Financial first reported a position in PFE in Q4 2019 and has held it in 28 quarters since. The position peaked at $3.33M in Q4 2022. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Key Financial held 48,466 shares of Pfizer worth $1.38M as of Q3 2026.
  • Key Financial sold 3,950 Pfizer shares in Q3 2026, an estimated $105K.
  • Pfizer made up 0.23% of Key Financial's portfolio in Q3 2026, its #79 holding.
  • Key Financial first reported a position in Pfizer in Q4 2019 and has held it in 28 quarters since.
  • Key Financial's Pfizer position peaked at $3.33M in Q4 2022.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.